Information about the upcoming ACP-I conference (formerly ACPEL) 13-16 March in Rotterdam. See also: @ACPinScience | @JudithRietjens @IKorfage @DorisvdSmissen
Sadly, it was hard to get this paper published. Apparently, it is hard to find a good home for papers about RCTs with so called “negative findings” (although we do not like this term). This warrants more discussion in the academic community! 10/10.
Two more thoughts. This was a great project. Collaborating across 6 countries helped hugely in understanding the complexities of ACP. Thank you, @JudithRietjens @GlenysCaswell @mold01@JabbarianL@SheilaPayne1 @PollockKristian @NancyPreston16 and those without twitter! 9/10
We did find that specialist palliative care was more likely in the intervention group (37% versus 27%). Also, patients in the intervention group more often had an AD in their hospital file (10% versus 3%). It was striking that these
numbers were rather low, though. 6/10
What did we find? Mean change in patients’ quality of life did not differ between intervention and control participants, nor did changes in symptoms, coping, patient satisfaction, and shared decision-making. 5/10
Who participated? Patients with advanced lung (stage III/IV) or colorectal (stage IV) cancer, WHO performance status 0–3, and at least 3 months life expectancy were eligible. We recruited in 23 hospitals in 6 countries: Belgium, Denmark, Italy, Netherlands, Slovenia, and UK. 4/10
The intervention had multiple components: (1) scripted ACP conversations between patients, families, and certified facilitators; (2) standardised leaflets; and (3)
standardised advance directives especially developed for this study. Intervention fidelity was high, 86%. 3/10
What did we do? This was a large study. In a cluster RCT, we randomized 1,117 patients: 442 intervention and 675 control of whom 809 (72%) completed the 12-week questionnaire. Patients in the intervention group were offered the ACTION Respecting Choices ACP intervention. 2/10
Recently we published the results of our ACTION study about the effectiveness of #advancecareplanning in patients with advanced cancer in 6 European countries in
@PLOSmedicine. https://t.co/iEXzSSjQWT
Here, we want to take you through the main findings and lessons 1/10
Proud of our team that held focus groups with patients with an implantable cardioverter defibrillator about #advancecareplanning and wrote this paper in @Heart_BMJ:
https://t.co/ypRxwLSPDS
@Palliatief_Utr @HollanderPasma Zou mooi zijn om ook expliciet aandacht te besteden aan oudere migranten en hun kinderen. Hoger % ouderen met dementie in die groep en weinig kennis van ziekte en voorzieningen.
Marijanne Engle presenting results of estimating and communicating prognosis in palliative care. There are many perceived communication barriers between physicians in different settings: GP, hospital and nursing home setting. Why is this? How can we solve it? #ACP#acpi2019